Background illustration for clinical trials search

Multiple Sclerosis Clinical Trials

Browse 309 multiple sclerosis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Multiple Sclerosis Implementation Network (Registry)

for
Multiple Sclerosis
Location: Cherry Hill NJ, Houston TX, Austin TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT07415824

Recruiting

Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients

for
Progressive Multiple Sclerosis, Depression
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 18+

Code: NCT07392879

Recruiting

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

for
Multiple Sclerosis
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70

Code: NCT07207148

Recruiting

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

for
Multiple Sclerosis
Location: New York NY, Washington D.C. DC, Milwaukee WI,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 60

Code: NCT07224373

Phase 1, Recruiting

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

for
Multiple Sclerosis (MS) Primary Progressive
Location: Livingston NJ, Raleigh NC, Orlando FL, Maitland FL,
Sponsor: Zenas BioPharma (USA), LLC

Sex: All

Age: 18 - 60

Code: NCT07067463

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

for
Multiple Sclerosis
Location: Maitland FL, Savannah GA, Atlanta GA, Birmingham AL,
Sponsor: Genentech, Inc.

Sex: All

Age: 18 - 65

Code: NCT07609719

Phase 4, Recruiting

Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)

for
Multiple Sclerosis
Location: Buffalo NY
Sponsor: State University of New York at Buffalo

Sex: All

Age: 55 - 70+

Code: NCT06463743

Phase 2, Recruiting

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

for
Multiple Sclerosis,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT07222618

Recruiting

Care in Multiple Sclerosis (MS)

for
Multiple Sclerosis
Location: Boston MA, Cleveland OH, Birmingham AL, Houston TX,
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 29

Code: NCT07011914

Recruiting

Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis

for
Spinal Cord Injury/Disorder, Stroke, Multiple Sclerosis,
Location: Cleveland OH
Sponsor: Louis Stokes VA Medical Center

Sex: All

Age: 18+

Code: NCT07768761

Recruiting

A Study of the MIND Diet for Persons With Multiple Sclerosis

for
Multiple Sclerosis
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18 - 70

Code: NCT06992115

Recruiting

Ocrevus Zunovo for MS: Mixed Methods

for
Multiple Sclerosis
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07710105

Recruiting

Implementation of an App-based Walking Aid Skills Training Program

for
Lower Limb; Sprain (Strain), Lower Limb Fracture, Stroke,
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 70+

Code: NCT05347875

Recruiting

HOBSCOTCH-MS-Efficacy Trial

for
Multiple Sclerosis, Cognitive Dysfunction, Memory Disorders,
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 20 - 70+

Code: NCT06951919

Recruiting

Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters

for
Spinal Cord Injuries (SCI), Multiple Sclerosis
Location: Urbana IL
Sponsor: University of Illinois at Urbana-Champaign

Sex: All

Age: 18+

Code: NCT07167680

Recruiting

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

for
Multiple Sclerosis (MS) - Relapsing-remitting
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18 - 65

Code: NCT06864936

Recruiting

Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

for
Multiple Sclerosis
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 65

Code: NCT07389590

Recruiting

Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment

for
Chronic Inflammatory Demyelinating Polyneuropathy,
Location: New York NY, Montreal, Ottawa, Salt Lake City UT,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18 - 70+

Code: NCT07304154

Phase 1, Recruiting

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

for
Multiple Sclerosis
Location: New York NY, Baltimore MD, Kansas City KS
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 60

Code: NCT07497399

Phase 2, Recruiting

Pathological Basis of MRI Signal Changes in Multiple Sclerosis

for
Multiple Sclerosis
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 70+

Code: NCT02659956

Recruiting

What is multiple sclerosis?

In MS, the immune system attacks myelin, the insulation around nerve fibers in the brain and spinal cord. Damaged spots, called lesions, slow or block nerve signals, which is why symptoms range from fatigue and numbness to vision problems and trouble walking. Symptoms and pace differ so much between people that MS is often called a disease with a thousand faces. It is not contagious, and it is not directly inherited. Worldwide about 2.9 million people live with MS, someone is diagnosed roughly every five minutes, and the average age at diagnosis is 32.

Research in this field carries one of the most striking findings in modern medicine: a 2022 study of more than 10 million US military members found that infection with the Epstein Barr virus, the common virus behind mononucleosis, raises MS risk 32 times, making it the leading suspected cause. Meanwhile treatment keeps expanding, with more than 20 approved disease modifying therapies, though the progressive forms still have almost none.

Article preview image

Interested in learning more about MS treatment? Read our guide: Multiple Sclerosis Treatment: 20+ Drugs and What's Next

Why Progressive Multiple Sclerosis Still Has Almost No Approved Treatments

The types of MS, and why they matter for trials

Types of multiple sclerosis clinical trials

Who can participate in MS trials?

Do MS trial participants get paid?

How to enroll in a clinical trial for multiple sclerosis